New triple attack on lung Cancer's deadly brain spread
NCT ID NCT07304739
Summary
This study is testing a combination of three treatments for a severe form of lung cancer that has spread to the brain and its protective lining. It will involve 30 adults with a specific genetic marker (EGFR mutation) who have not yet received treatment for their advanced cancer. The goal is to see if using a targeted pill, specialized chemotherapy injected into the spine, and precise radiation together can better control the cancer in the brain and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CANGZHOU People's Hospital
RECRUITINGCangzhou, Hebei, 061001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin Huanhu Hospital
RECRUITINGTianjin, Tianjin Municipality, 300350, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tianjin medical university cancer hospital and institute
RECRUITINGTianjin, Tianjin Municipality, 300060, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.